292 related articles for article (PubMed ID: 19770671)
1. Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogs.
Polakowski JS; King AJ; Campbell TJ; Nelson RA; Preusser LC; Kempf-Grote AJ; Marsh KC; Gintant GA; Cox BF; Mittelstadt SW
J Cardiovasc Pharmacol; 2009 Dec; 54(6):543-51. PubMed ID: 19770671
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of buprenorphine in anesthetized dogs.
Martinez EA; Hartsfield SM; Melendez LD; Matthews NS; Slater MR
Am J Vet Res; 1997 Nov; 58(11):1280-4. PubMed ID: 9361893
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of vasopressors in isoflurane-anesthetized dogs before and after hemorrhage.
Curtis MB; Bednarski RM; Majors L
Am J Vet Res; 1989 Nov; 50(11):1866-71. PubMed ID: 2619117
[TBL] [Abstract][Full Text] [Related]
4. Strategic integration of in vivo cardiovascular models during lead optimization: predictive value of 4 models independent of species, route of administration, and influence of anesthesia.
Fryer RM; Harrison PC; Muthukumarana A; Nodop Mazurek SG; Ng KJ; Chen RR; Harrington KE; Dinallo RM; Chi L; Reinhart GA
J Cardiovasc Pharmacol; 2012 Apr; 59(4):369-76. PubMed ID: 22179024
[TBL] [Abstract][Full Text] [Related]
5. Effects of CP-532,623 and torcetrapib, cholesteryl ester transfer protein inhibitors, on arterial blood pressure.
Blasi E; Bamberger M; Knight D; Engwall M; Wolk R; Winter S; Betts A; John-Baptiste A; Keiser J
J Cardiovasc Pharmacol; 2009 Jun; 53(6):507-16. PubMed ID: 19455053
[TBL] [Abstract][Full Text] [Related]
6. Effects of hyperbaric oxygen on ventricular performance, pulmonary blood volume, and systemic and pulmonary vascular resistance.
Abel FL; McNamee JE; Cone DL; Clarke D; Tao J
Undersea Hyperb Med; 2000; 27(2):67-73. PubMed ID: 11011796
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced effects on cardiovascular function in pentobarbital anesthetized guinea-pigs: invasive LVP measurements versus the QA interval.
Johnson DM; Geys R; Lissens J; Guns PJ
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):152-9. PubMed ID: 22813982
[TBL] [Abstract][Full Text] [Related]
8. Characteristic cardiovascular effects of RA642, a pyrimido-pyrimidine derivative, in anesthetized dogs.
Koyama S
J Pharmacol Exp Ther; 1985 May; 233(2):480-4. PubMed ID: 3999030
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of vasopressors in halothane-anesthetized dogs before and after hemorrhage.
Curtis MB; Bednarski RM; Majors L
Am J Vet Res; 1989 Nov; 50(11):1859-65. PubMed ID: 2619116
[TBL] [Abstract][Full Text] [Related]
10. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
Atkins CE; Keene BW; McGuirk SM; Sato T
Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
[TBL] [Abstract][Full Text] [Related]
11. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
13. Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.
Vergeer M; Bots ML; van Leuven SI; Basart DC; Sijbrands EJ; Evans GW; Grobbee DE; Visseren FL; Stalenhoef AF; Stroes ES; Kastelein JJ
Circulation; 2008 Dec; 118(24):2515-22. PubMed ID: 19029469
[TBL] [Abstract][Full Text] [Related]
14. Fantofarone (SR 33557): cardiovascular actions in anesthetized dogs.
Barthélémy G; Chatelain P; Manning A
Arch Int Pharmacodyn Ther; 1994; 327(2):204-19. PubMed ID: 7979829
[TBL] [Abstract][Full Text] [Related]
15. Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.
Nomura H; Nakamura Y; Cao X; Honda A; Katagi J; Ohara H; Izumi-Nakaseko H; Satoh Y; Ando K; Sugiyama A
Eur J Pharmacol; 2015 Aug; 761():217-25. PubMed ID: 26073024
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
18. Effects of ephedrine on cardiovascular function and oxygen delivery in isoflurane-anesthetized dogs.
Wagner AE; Dunlop CI; Chapman PL
Am J Vet Res; 1993 Nov; 54(11):1917-22. PubMed ID: 8291773
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of epidurally administered morphine and a xylazine-morphine combination in isoflurane-anesthetized dogs.
Keegan RD; Greene SA; Weil AB
Am J Vet Res; 1995 Apr; 56(4):496-500. PubMed ID: 7785829
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary effects of halothane in hypovolemic dogs.
Pascoe PJ; Haskins SC; Ilkiw JE; Patz JD
Am J Vet Res; 1994 Jan; 55(1):121-6. PubMed ID: 8141484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
